samedan logo
 
 
 
spacer
home > pmps > summer 2019 > connecting the disconnected
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Connecting the Disconnected

The US Drug Supply Chain Security Act and the EU Falsified Medicines Directive, introduced late 2018 and early 2019 respectively, require that all pharmaceutical products must be traceable across the entire supply chain. Serialisation or ‘track and trace’ are terms commonly used to describe these requirements, and this is an initiative that’s gathering pace globally in the war against counterfeit medicines.

Likewise, the medical device industry has been responding to new regulations that increase levels of patient safety. The FDA’s Unique Device Identification (UDI) System and the EU’s medical device regulations/ in vitro diagnostic regulations compel device manufacturers to allocate and submit a UDI for every device sold. With serialisation, UDI is a global initiative with Brazil, China, India, and South Korea, among others.

While differing in their detail, aspects of traceability are common to both. With increasing convergence of pharma and medical device companies, perhaps it is time to look for solutions that go beyond today’s regulatory requirements to bring organisation-wide transparency and traceability to product and package labelling.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kallik is a leading provider of integrated, cloud-based labelling and artwork management solutions for highly regulated global industries. Their solutions help the industry accelerate time to market, reduce the risk of noncompliance, and eliminate costly product recalls caused by labelling inaccuracies. They also help organisations overcome process bottlenecks and achieve a faster return on investment through increased transparency and greater levels of collaboration.
spacer
Graham Francis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cognizant Shared Investigator Platform for Life Sciences Reaches Major Milestone in Accelerating Drug Discovery

Cognizant (Nasdaq: CTSH) announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution, has reached a new milestone of over 100,000 users in 84 countries. The platform has become increasingly critical to progressing clinical trials as prevailing social distancing norms have significantly curtailed in-person collaboration.
More info >>

White Papers

Pharmaceutical Companies: Outsourcing Combination Product Manufacturing

Phillips-Medisize

Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement